Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v2.4.0.8
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (USD $)
In Thousands, except Share data
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Total
Balances at Mar. 31, 2012 $ 17 $ 129,052 $ (142) $ (120,847) $ 8,080
Balances (in shares) at Mar. 31, 2012 1,688,807        
Stock issued for asset acquisition - CollabRx 2 930 0 0 932
Stock issued for asset acquisition - CollabRx (in shares) 236,433        
Stock compensation expense and released restricted stock units 0 695 0 0 695
Stock compensation expense and released restricted stock units (in shares) 27,740        
Warrants exchanged for services 0 (75) 0 0 (75)
Net loss 0 0 0 (3,928) (3,928)
Balances at Mar. 31, 2013 19 130,602 (142) (124,775) 5,704
Balances (in shares) at Mar. 31, 2013 1,952,980       1,952,980
Stock issued in connection with 2014 ATM Plan 0 6 0 0 6
Stock issued in connection with 2014 ATM Plan (in shares) 1,810        
Stock compensation expense and released option shares 0 35 0 0 35
Stock compensation expense and released option shares (in shares) 10,000        
Stock compensation expense and released restricted stock units 1 351 0 0 352
Stock compensation expense and released restricted stock units (in shares) 40,397        
Cumulative translation adjustment 0 0 142   142
Net loss 0 0 0 (3,314) (3,314)
Balances at Mar. 31, 2014 $ 20 $ 130,994 $ 0 $ (128,039) $ 2,925
Balances (in shares) at Mar. 31, 2014 2,005,187       2,005,187